Hong Kong SAR |
|
|
中華人民共和國香港特別行政區 Hong Kong Special Administrative Region of the People's Republic of China Flag Emblem Motto: none Anthem: March of the Volunteers Hong Kong uses the national anthem of the PRC Capital none Historically, the capital was Victoria City; government headquarters located in Central and Western District 22°17′N 114°08′E Most populated district Sha Tin District Official language(s) ...
Wikipedia - [full article]
Hong Kong SAR Clinical Trials
- Open Label Tolerability and Safety Study of KRX-101 in Australia, New Zealand, and Hong Kong
ClinicalTrials.gov Identifier: NCT00462202 - Recruiting
Diabetic Nephropathy
- Non Alcoholic Fatty Liver Disease (NAFLD) in Hong Kong
ClinicalTrials.gov Identifier: NCT00577044 - Active, not recruiting
Fatty Liver
- Psychopathology of Normal-Tension Glaucoma in Hong Kong Chinese Out-Patient
ClinicalTrials.gov Identifier: NCT00324181 - Recruiting
Glaucoma
- Infections After Renal Transplantation: Diseases Pattern in Hong Kong
ClinicalTrials.gov Identifier: NCT00498017 - Recruiting
Kidney Transplantation; Infection
- A Multi-Centre Clinical Study in Spinal Cord Injury Patients in Mainland China and Hong Kong
ClinicalTrials.gov Identifier: NCT00517374 - Recruiting
Spinal Cord Injuries
- Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults
ClinicalTrials.gov Identifier: NCT00110279 - Active, not recruiting
Influenza; Virus Diseases
- Once-Daily Investigational Nasal Spray In Adults And Adolescents With Seasonal Allergic Rhinitis (SAR)
ClinicalTrials.gov Identifier: NCT00197262 - Active, not recruiting
Rhinitis
- Single Nucleotide Polymorphism (SNP) in Schizophrenia and Schizophrenia Spectrum Disorders: a Population Association Analysis With Hong Kong Chinese
ClinicalTrials.gov Identifier: NCT00562926 - Completed
Schizophrenia
- PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-Arm)
ClinicalTrials.gov Identifier: NCT00574210 - Recruiting
Seasonal Allergic Rhinitis; Hay Fever; Rhinoconjunctivitis
- Efficacy, Safety and PK of Once or Twice Daily Bilastine (10 or 20 mg) Compared With Placebo in the Symptomatic Treatment of SAR
ClinicalTrials.gov Identifier: NCT00574379 - Recruiting
Seasonal Allergic Rhinitis; Hay Fever; Allergic Conjunctivitis; Hypersensitivity
- A Study to Evaluate a Once-Daily Investigational Nasal Spray in Adults and Adolescents with Seasonal Allergic Rhinitis (SAR)
ClinicalTrials.gov Identifier: NCT00115622 - Active, not recruiting
Rhinitis, Allergic, Seasonal
- Compare the Efficacy of Levocetirizine and Montelukast to Placebo in Reducing SAR Symptoms in Ragweed Sensitive Subjects
ClinicalTrials.gov Identifier: NCT00295022 - Completed
Rhinitis, Allergic, Seasonal
- Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR
ClinicalTrials.gov Identifier: NCT00521040 - Completed
Rhinitis, Allergic, Seasonal
- Compare the Efficacy of Levocetirizine to Placebo in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen
ClinicalTrials.gov Identifier: NCT00291642 - Completed
Rhinitis, Allergic, Seasonal
- Compare the Efficacy of Levocetirizine to Montelukast in Reducing Symptoms of SAR in Sensitive Subjects Exposed to Ragweed Pollen
ClinicalTrials.gov Identifier: NCT00315523 - Completed
Rhinitis, Allergic, Seasonal
- Effect of Loratadine/Montelukast Combination on Congestion in SAR Patients Exposed to Pollen in an EEU (Study P04822)(COMPLETED)
ClinicalTrials.gov Identifier: NCT00423995 - Completed
Seasonal Allergic Rhinitis
- A 5-Way Treatment Period Trial of Single Doses of Intranasal GSK256066 in Patients With Rhinitis
ClinicalTrials.gov Identifier: NCT00464568 - Completed
Seasonal Allergic Rhinitis,; SAR
- The Effects of Phenylephrine Compared With Those of Placebo and Pseudoephedrine on Nasal Congestion in Subjects With Seasonal Allergic Rhinitis (SAR) (Study P04579)(COMPLETED)
ClinicalTrials.gov Identifier: NCT00276016 - Completed
Rhinitis, Allergic, Seasonal
- This Study Contains an Active Drug Treatment Group With Mometasone Furoate Nasal Spray and a Placebo (Dummy) Treatment Group for Seasonal Allergic Rhinitis (SAR). (Study P05073)(COMPLETED)
ClinicalTrials.gov Identifier: NCT00491504 - Completed
Seasonal Allergic Rhinitis
- Efficacy and Safety of Nasonex vs. Placebo in Subjects with SAR and Concomitant Asthma
ClinicalTrials.gov Identifier: NCT00070707 - Completed
Rhinitis, Allergic, Seasonal; Asthma

Not Signed In -

